Category Archives:

(Reuters) -Harley-Davidson Inc's electric-motorcycle division LiveWire will go public through a merger with a blank-check firm in a deal valuing it at $1.77 billion including debt, the company said on...

By Shreyashi Sanyal (Reuters) - U.S. stock index futures rose on Monday, led by gains in Apple which neared $3 trillion in market capitalization, while investors looked ahead to the Federal Reserve's ...

ZURICH (Reuters) - Credit Suisse is planning a sixth payout in mid-December of around $400 million to investors in frozen supply chain finance funds linked to Greensill, bringing the total amount retu...

By Alex Lawler LONDON (Reuters) - OPEC on Monday raised its world oil demand forecast for the first quarter of 2022 but left its full-year growth prediction steady, saying the Omicron coronavirus vari...

By Lisa Pauline Mattackal and Vidya Ranganathan (Reuters) - As bitcoin, the world's largest cryptocurrency, struggles to recover after a massive crash, regulatory and private sector focus has turned t...

By Svea Herbst-Bayliss BOSTON (Reuters) - Activist investment firm Land & Buildings Investment Management is seeking a seat on the board of American Campus Communities (ACC), according to people famil...

JERUSALEM (Reuters) - Israel's high-tech sector raised a record $25.4 billion so far in 2021, up 136% over 2020, Start-Up Nation Central said in a report on Monday. It noted that FinTech, enterprise I...

By Asif Shahzad ISLAMABAD (Reuters) - When Pakistan's annual inflation rate hit 11.5% in November, the statistics office put a number on a phenomenon that was already painfully clear to the poor and t...

KIBBUTZ YAHEL, Israel (Reuters) - The southern tip of Israel is a rocky desert where solar panels are abundant and the sun, when shining, is the source of nearly all electricity. Once it sets, however...

(Reuters) -Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday. Pfizer...